Biocept, Inc.
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthc…
Medical - Diagnostics & Research
US, San Diego [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Biocept, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBiocept, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Biocept, Inc..
If you want to see a demo, head over to the financial segments of AAPL